Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Yuan Yan Yao Gang Life Science is a Hong Kong-based biotechnology company specializing in the research, development, and commercialization of longevity and anti-aging products. The company is primarily known for its high-purity Nicotinamide Mononucleotide (NMN) supplements, which are marketed under the Original Drug Port brand. Utilizing enzymatic synthesis technologies, the company focuses on NAD+ precursors to address age-related physiological decline and metabolic health. While its primary revenue comes from the nutraceutical market, it positions itself as a life sciences entity dedicated to applying pharmaceutical-grade standards to dietary supplements. The company operates a significant presence in both Hong Kong and Shenzhen to manage its R&D and distribution networks across the Greater China region.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 原研药港生命科学.